Clinical trial
A Multicenter, Placebo-controlled Clinical Study of Berberine Hydrochloride in Preventing Recurrence and Carcinogenesis After Endoscopic Removal of Colorectal Adenomas:6-year Retrospective Follow-up Data
NCT06629051 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Placebo-controlled Clinical Study of Berberine Hydrochloride in Preventing Recurrence and Carcinogenesis After Endoscopic Removal of Colorectal Adenomas:6-year Retrospective Follow-up Data
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 4, 2024
- Completion date
- December 31, 2024
- Enrollment
- 891 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal adenoma, colorectal cancer control and prevention, colorectal polyps